Surgical Endoscopy

, Volume 32, Issue 3, pp 1248–1254 | Cite as

Reduction of Framingham BMI score after rapid weight loss in severely obese subjects undergoing sleeve gastrectomy: a single institution experience

  • David Gutierrez-Blanco
  • David Funes-Romero
  • SriGita Madiraju
  • Federico Perez-Quirante
  • Emanuele Lo Menzo
  • Samuel Szomstein
  • Raul J. Rosenthal
Article

Abstract

Background

There is vast evidence that supports the importance of obesity in the pathogenesis and progression of cardiovascular disease. Rapid weight loss induced by laparoscopic Roux-en-Y gastric bypass (RYGB) and adjustable gastric banding (LAGB) has proven beneficial. The aim of this study is to evaluate laparoscopic sleeve gastrectomy (LSG) as an alternative treatment modality and its impact on the Framingham-BMI 10-year risk score.

Methods

We retrospectively reviewed all patients that underwent bariatric surgery at our institution between 2010 and 2014. Patients who met the criteria for calculating the Framingham BMI 10-year risk score were included. Data collected included baseline demographics, perioperative parameters such as tobacco use, diagnosis of diabetes, treatment for hypertension, BMI and postoperative outcomes at 3 and 12 months.

Results

From our 1129 bariatric patients, 358 (31.7%) met criteria for the Framingham BMI 10-year risk score calculation. LSG was the most prevalent surgery 61.45% (N = 220) followed by LRYGB 22.06% (N = 79). Females composed 69% (N = 248) of our population. The average age for females was 52.3 ± 10.8 years and for males 54.07 ± 11.2 years. The initial Framingham 10-year score risk was significantly higher in males compared with females (36.16% ± 22.3 vs. 16.97% ± 15.6 (p < 0.001)). After 12-month follow-up, the absolute risk reduction in males was 11.58% (p < 0.001) and 6.17% in females (p < 0.001). The preoperative heart age was high in females and males (69.23 ± 15.72 years and 73.55 ± 13.55 years, respectively (p = 0.012)), and after 12 months it was reduced 7.19 years in females (p < 0.001) and 7.04 years in males (p < 0.001). The percentage of estimated BMI loss at 1 year was 64.43% in females and 60.69% in males.

Conclusion

Sleeve gastrectomy has demonstrated to be an effective method of treatment for obesity. Our results suggest that rapid weight loss after LSG has a positive impact in the reduction of the 10-year cardiovascular disease risk. Further prospective studies may be needed to better assess these findings.

Keywords

Bariatric surgery Framingham score risk reduction Cardiovascular risk reduction 

Notes

Compliance with ethical standards

Disclosure

Dr. David Gutierrez-Blanco, Dr. David Funes-Romero, SriGita Madiraju, Dr. Federico Perez-Quirante, Dr. Emanuele Lo Menzo, Dr. Samuel Szomstein and Dr. Raul J. Rosenthal have no conflicts of interest or financial ties to disclose.

References

  1. 1.
    Bassett MT, Perl S (2004) Obesity: the public health challenge of our time. Am J Public Health 94:1477. doi: 10.2105/AJPH.94.9.1477 CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Statistics NC for H (2012) Healthy people 2010: final reviewGoogle Scholar
  3. 3.
    Rabkin SW, Mathewson FA, Hsu PH, Epstein F, Ostrander L, Johnson B et al, Kannel W, LeBauer E, Dawber T et al, Stamler J, Berkson D, Morjonner L et al, Chapman J, Coulson A, Clark V et al, Paul O, Lepper M, Phelon W et al, Keys A, Aronovis C, Blackburn H et al, Mathewson F, Varnam G, Mathewson F, Brereton D, Keltie W et al, Paul O, Schatz M, Walker S, Duncan D, Paffenbarger R, Wing A, Brozek J, Seltzer C, Keys A, Fedonza F, Kornonen M et al, Goldbourt U, Medalie J, Kannel W, Dawber T, Kagan A et al, Chapman J, Massey F, Gordon T, Kannel W, Gordon T, Schwartz M, Palmieri MG, Costos R, Schiffman J et al, Kannel W, Doyle J, McNamara P et al, Ashley F, Kannel W, Heyden S, Tyroler H, Hames C, Walker W, Medalie J, Snyder M, Groen J et al, Kieller L, Lilienfeld A, Fisher R, Spain D, Brodess V, Mohr C, Liberthson R, Nagel E, Herschman J et al, Alexander J, Han J, Haeren J, Corday E, Corday S (1977) Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: the Manitoba Study. Am J Cardiol 39:452–458. doi: 10.1016/S0002-9149(77)80104-5
  4. 4.
    Gomes F, Telo DF, Souza HP, Nicolau JC, Halpern A, Serrano CV (2010) Obesity and coronary artery disease: role of vascular inflammation. Arq Bras Cardiol 94:255–261, 273–279, 260–266Google Scholar
  5. 5.
    Vilahur G, Badimon JJ, Bugiardini R, Badimon L (2014) Perspectives: the burden of cardiovascular risk factors and coronary heart disease in Europe and worldwide. Eur Hear J Suppl 16:A7–A11. doi: 10.1093/eurheartj/sut003 CrossRefGoogle Scholar
  6. 6.
    Mahmooda SS, Levy D, Vasan RS, Wang TJ (2014) The Framingham heart study and the epidemiology of cardiovascular diseases: a historical perspective. Lancet 383:1933–1945. doi: 10.1016/S0140-6736(13)61752-3.The CrossRefGoogle Scholar
  7. 7.
    D’Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB (2008) General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation 117:743–753. doi: 10.1161/CIRCULATIONAHA.107.699579 CrossRefPubMedGoogle Scholar
  8. 8.
    Framingham T, Study H (2015) Annals of internal medicine a risk score for predicting near-term incidence of hypertension. Ann Intern MedGoogle Scholar
  9. 9.
    Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, Bucher HC, Nordmann AJ (2013) Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ 347:f5934. doi: 10.1136/bmj.f5934 CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Madura JA, Dibaise JK (2012) Quick fix or long-term cure? Pros and cons of bariatric surgery. F1000 Med Rep 4:19. doi: 10.3410/M4-19
  11. 11.
    Aminian A, Jamal MH, Andalib A, Batayyah E, Romero-Talamás H, Chand B, Schauer PR, Brethauer SA (2015) Is laparoscopic bariatric surgery a safe option in extremely high-risk morbidly obese patients? J Laparoendosc Adv Surg Tech 25:707–711. doi: 10.1089/lap.2015.0013 CrossRefGoogle Scholar
  12. 12.
    Colquitt JL, Pickett K, Loveman E, Frampton GK (2014) Surgery for weight loss in adults. Cochrane Database Syst Rev 8:CD003641. doi: 10.1002/14651858.CD003641.pub4
  13. 13.
    Batsis JA, Sarr MG, Collazo-Clavell ML, Thomas RJ, Romero-Corral A, Somers VK, Lopez-Jimenez F (2008) Cardiovascular risk after bariatric surgery for obesity. Am J Cardiol 102:930–937. doi: 10.1016/j.amjcard.2008.05.040 CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Aftab H, Risstad H, Søvik TT, Tomm Bernklev PD, Hewitt S, Kristinsson JA, Mala T (2014) Five-year outcome after gastric bypass for morbid obesity in a Norwegian cohort. Surg Obes Relat Dis 10:71–78. doi: 10.1016/j.soard.2013.05.003 CrossRefPubMedGoogle Scholar
  15. 15.
    Arterburn D, Schauer DP, Wise RE, Gersin KS, Fischer DR, Selwyn CA, Erisman A, Tsevat J (2009) Change in predicted 10-year cardiovascular risk following laparoscopic roux-en-Y gastric bypass surgery. Obes Surg 19:184–189. doi: 10.1007/s11695-008-9534-7 CrossRefPubMedGoogle Scholar
  16. 16.
    Largent JA, Vasey J, Bessonova L, Okerson T, Wong ND (2013) Reduction in Framingham risk of cardiovascular disease in obese patients undergoing laparoscopic adjustable gastric banding. Adv Ther 30:684–696. doi: 10.1007/s12325-013-0045-0 CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    What the numbers reveal. http://connect.asmbs.org/may-2014-bariatric-surgery-growth.html. Accessed 12 November 2015
  18. 18.
    ASMBS Estimate of Bariatric Surgery Numbers, 2011–2015Google Scholar
  19. 19.
    Heneghan HM, Meron-Eldar S, Brethauer SA, Schauer PR, Young JB (2011) Effect of bariatric surgery on cardiovascular risk profile. Am J Cardiol 108:1499–1507. doi: 10.1016/j.amjcard.2011.06.076 CrossRefPubMedGoogle Scholar
  20. 20.
    Benaiges D, Goday A, Ramon JM, Hernandez E, Pera M, Cano JF (2011) Laparoscopic sleeve gastrectomy and laparoscopic gastric bypass are equally effective for reduction of cardiovascular risk in severely obese patients at one year of follow-up. Surg Obes Relat Dis 7:575–580. doi: 10.1016/j.soard.2011.03.002 CrossRefPubMedGoogle Scholar
  21. 21.
    Donadelli SP, Salgado W, Marchini JS, Schmidt A, Amato CAF, Ceneviva R, Dos Santos JE, Nonino CB (2011) Change in predicted 10-year cardiovascular risk following Roux-en-Y gastric bypass surgery: who benefits? Obes Surg 21:569–573. doi: 10.1007/s11695-010-0348-z CrossRefPubMedGoogle Scholar
  22. 22.
    Iancu M, Copăescu C, Şerban M, Ginghină C (2013) Laparoscopic sleeve gastrectomy reduces the predicted coronary heart disease risk and the vascular age in obese subjects. Chirurgia (Bucur) 108:659–665Google Scholar
  23. 23.
    Marin-Perez P, Betancourt A, Lo Menzo E, Szomstein S, Rosenthal R (2014) Outcomes after laparoscopic conversion of failed adjustable gastric banding to sleeve gastrectomy or Roux-en-Y gastric bypass. Br J Surg 101:254–260. doi: 10.1002/bjs.9344 CrossRefPubMedGoogle Scholar
  24. 24.
    Nguyen D, Dip F, Huaco JA, Moon R, Ahmad H, LoMenzo E, Szomstein S, Rosenthal R (2015) Outcomes of revisional treatment modalities in non-complicated Roux-En-Y gastric bypass patients with weight regain. Obes Surg 25:928–934. doi: 10.1007/s11695-015-1615-9 CrossRefPubMedGoogle Scholar
  25. 25.
    Schiavon CA, Drager LF, Bortolotto LA, Amodeo C, Ikeoka D, Berwanger O, Cohen RV (2016) The role of metabolic surgery on blood pressure control. Curr Atheroscler Rep. doi: 10.1007/s11883-016-0598-x PubMedGoogle Scholar
  26. 26.
    Schauer P, Bhatt D, Kirwan J, Wolski K, Brethauer S, Navaneethan S, Aminian A, Pothier C, Kim E, Nissen S, Kashyap S (2014) Bariatric surgery versus intensive medical therapy for diabetes. N Engl J Med 371:680–682. doi: 10.1056/NEJMoa1401329 CrossRefGoogle Scholar
  27. 27.
    Perrone F, Bianciardi E, Benavoli D, Tognoni V, Niolu C, Siracusano A, Gaspari AL, Gentileschi P (2015) Gender influence on long-term weight loss and comorbidities after laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass: a prospective study with a 5-year follow-up. Obes Surg. doi: 10.1007/s11695-015-1746-z Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  • David Gutierrez-Blanco
    • 1
  • David Funes-Romero
    • 1
  • SriGita Madiraju
    • 1
  • Federico Perez-Quirante
    • 1
  • Emanuele Lo Menzo
    • 1
  • Samuel Szomstein
    • 1
  • Raul J. Rosenthal
    • 1
  1. 1.Department of General Surgery and The Bariatric and Metabolic InstituteCleveland Clinic FloridaWestonUSA

Personalised recommendations